KLF4 and colorectal carcinoma: miR-7, for instance, suppresses KLF4 in breast CSCs, whereas miR-25-3p (a metastasis-promoting miRNA) targets KLF4 and eventually vascular permeability and angiogenesis in CRC [27,28].